DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
MAPK signaling pathway	R-HSA-9652817	map04010	rimexolone	5311412	drug-path
Parkinson's disease	R-HSA-1643685	0	rimexolone	5311412	drug-path
Cytokine-cytokine receptor interaction	R-HSA-6788467	map04060	rimexolone	5311412	drug-path
GnRH signaling pathway	R-HSA-168638	map04912	rimexolone	5311412	drug-path
Alzheimer's disease	R-HSA-1643685	0	torasemide	5338	drug-path
Olfactory transduction	R-HSA-9751605	map04740	torasemide	5338	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	torasemide	5338	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	torasemide	5338	drug-path
Parkinson's disease	R-HSA-1643685	0	torasemide	5338	drug-path
Alzheimer's disease	R-HSA-1643685	0	lymecycline	89034	drug-path
Autoimmune thyroid disease	R-HSA-1643685	map05320	lymecycline	89034	drug-path
Olfactory transduction	R-HSA-9751605	map04740	lymecycline	89034	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	lymecycline	89034	drug-path
Epithelial cell signaling in Helicobacter pylori infection	0	map05120	lymecycline	89034	drug-path
Jak-STAT signaling pathway	R-HSA-168638	map04630	lymecycline	89034	drug-path
Type I diabetes mellitus	R-HSA-5683209	map04940	lymecycline	89034	drug-path
Renal cell carcinoma	R-HSA-9794523	map05211	lymecycline	89034	drug-path
B cell receptor signaling pathway	R-HSA-983705	map04662	lymecycline	89034	drug-path
Pathways in cancer	R-HSA-9824443	map05200	lymecycline	89034	drug-path
Wnt signaling pathway	R-HSA-195721	map04310	lymecycline	89034	drug-path